Alu retrotransposons promote differentiation of human carcinoma cells through the aryl hydrocarbon receptor

Nucleic Acids Res. 2016 Jun 2;44(10):4665-83. doi: 10.1093/nar/gkw095. Epub 2016 Feb 15.

Abstract

Cell differentiation is a central process in development and in cancer growth and dissemination. OCT4 (POU5F1) and NANOG are essential for cell stemness and pluripotency; yet, the mechanisms that regulate their expression remain largely unknown. Repetitive elements account for almost half of the Human Genome; still, their role in gene regulation is poorly understood. Here, we show that the dioxin receptor (AHR) leads to differentiation of human carcinoma cells through the transcriptional upregulation of Alu retrotransposons, whose RNA transcripts can repress pluripotency genes. Despite the genome-wide presence of Alu elements, we provide evidences that those located at the NANOG and OCT4 promoters bind AHR, are transcribed by RNA polymerase-III and repress NANOG and OCT4 in differentiated cells. OCT4 and NANOG repression likely involves processing of Alu-derived transcripts through the miRNA machinery involving the Microprocessor and RISC. Consistently, stable AHR knockdown led to basal undifferentiation, impaired Alus transcription and blockade of OCT4 and NANOG repression. We suggest that transcripts produced from AHR-regulated Alu retrotransposons may control the expression of stemness genes OCT4 and NANOG during differentiation of carcinoma cells. The control of discrete Alu elements by specific transcription factors may have a dynamic role in genome regulation under physiological and diseased conditions.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alu Elements*
  • Animals
  • Basic Helix-Loop-Helix Transcription Factors / metabolism
  • Basic Helix-Loop-Helix Transcription Factors / physiology*
  • Carcinoma / pathology
  • Cell Differentiation / drug effects
  • Cell Differentiation / genetics*
  • Cell Line, Tumor
  • Cell Nucleus / metabolism
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • Mice
  • MicroRNAs / metabolism
  • Nanog Homeobox Protein / genetics
  • Octamer Transcription Factor-3 / genetics
  • Promoter Regions, Genetic
  • RNA Polymerase III / metabolism
  • Receptors, Aryl Hydrocarbon / metabolism
  • Receptors, Aryl Hydrocarbon / physiology*
  • Teratocarcinoma / enzymology
  • Teratocarcinoma / genetics*
  • Teratocarcinoma / metabolism
  • Teratocarcinoma / pathology
  • Teratoma / genetics
  • Teratoma / metabolism
  • Transcription, Genetic
  • Tretinoin / pharmacology

Substances

  • AHR protein, human
  • Basic Helix-Loop-Helix Transcription Factors
  • MicroRNAs
  • Nanog Homeobox Protein
  • Octamer Transcription Factor-3
  • Receptors, Aryl Hydrocarbon
  • Tretinoin
  • RNA Polymerase III